Ocugen Inc (OCGN)
0.9058
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.9058
0.00 (0.00%)
After-Hours: 16:36
Ocugen Total Liabilities (Quarterly): 21.31M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 21.31M |
June 30, 2024 | 23.62M |
March 31, 2024 | 21.53M |
December 31, 2023 | 23.98M |
September 30, 2023 | 16.29M |
June 30, 2023 | 18.70M |
March 31, 2023 | 20.50M |
December 31, 2022 | 34.65M |
September 30, 2022 | 20.94M |
June 30, 2022 | 15.98M |
March 31, 2022 | 10.60M |
December 31, 2021 | 9.943M |
September 30, 2021 | 9.202M |
June 30, 2021 | 7.842M |
March 31, 2021 | 7.358M |
December 31, 2020 | 5.826M |
September 30, 2020 | 6.118M |
June 30, 2020 | 9.136M |
March 31, 2020 | 5.017M |
December 31, 2019 | 5.789M |
September 30, 2019 | 36.71M |
June 30, 2019 | 11.93M |
Date | Value |
---|---|
March 31, 2019 | 20.37M |
December 31, 2018 | 17.89M |
September 30, 2018 | 20.56M |
June 30, 2018 | 38.59M |
March 31, 2018 | 41.40M |
December 31, 2017 | 22.30M |
September 30, 2017 | 20.64M |
June 30, 2017 | 21.32M |
March 31, 2017 | 21.34M |
December 31, 2016 | 22.51M |
September 30, 2016 | 38.76M |
June 30, 2016 | 8.389M |
March 31, 2016 | 7.923M |
December 31, 2015 | 8.588M |
September 30, 2015 | 9.125M |
June 30, 2015 | 9.373M |
March 31, 2015 | 10.36M |
December 31, 2014 | 11.29M |
September 30, 2014 | 8.967M |
June 30, 2014 | 105.44M |
December 31, 2013 | 90.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.017M
Minimum
Mar 2020
34.65M
Maximum
Dec 2022
14.72M
Average
13.29M
Median
Total Liabilities (Quarterly) Benchmarks
Cytokinetics Inc | 1.450B |
Scholar Rock Holding Corp | 99.94M |
Mirum Pharmaceuticals Inc | 435.87M |
SpringWorks Therapeutics Inc | 76.30M |
NeuroBo Pharmaceuticals Inc | 9.193M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 61.94M |
Shareholders Equity (Quarterly) | 40.63M |
Debt to Equity Ratio | 0.0711 |
Current Ratio | 2.580 |
Net Debt Paydown Yield | -0.01% |